You are here: Industry Insights > oncology

News List

New Study Finds COVID-19 Substantially Reduced Cancer Screenings, Diagnosis, and Treatments in 2020 prnewswire
October 22, 2020
Breast, colon, prostate, and lung cancers did not stop for COVID-19 in 2020, but screenings and treatments did. Dramatically. The result, say doctors, could be a catastrophe in the making.
Boehringer expands oncology partnership with Oxford BioTherapeutics pharmaceutical-technology
October 16, 2020
Boehringer Ingelheim has announced the expansion of its partnership with UK-based Oxford BioTherapeutics (OBT) to discover novel selective targets for strategic cancer indications to deliver treatments for cancer patients.
Kanaph Therapeutics Closes 21M USD Series B Funding prnasia
October 15, 2020
Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules, recently completed their Series B funding of 21M USD in South Korea.
Antengene, WuXi Biologics Ink Innovative Oncology R&D Alliance contractpharma
October 14, 2020
Partner for the development and production of novel drugs, and to jointly promote R&D of innovative oncology therapies.
Pfizer and CStone to collaborate for oncology therapies in China expresspharma
October 09, 2020
CStone to receive up to $280 million in milestone payments for sugemalimab, and additional royalties.
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData expresspharma
October 09, 2020
There are 106 bispecific antibody molecules in the pipeline and 263 ongoing/planning to enrol clinical trials involving a bispecific antibody.
Accenture reveals data science project for paediatric leukaemia pharmatimes
September 30, 2020
Accenture Applied Intelligence announced a new data and analytics approach to manage and derive insights from paediatric acute myeloid leukaemia (AML) genomic data, with the potential to improve precision medicine.
New Guidelines for Maximizing Cures and Minimizing Side Effects in Children with Hodgkin Lymphoma prnasia
September 30, 2020
The National Comprehensive Cancer Network® (NCCN®) announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pediatric Hodgkin Lymphoma.
MSD partners with Seattle Genetics on two new oncology projects pharmatimes
September 16, 2020
MSD, known as Merck in the US and Canada, has announced two new oncology collaborations with biotech company and oncology specialist Seattle Genetics.
Lupin signs exclusive distribution deal with ForDoz Pharma for complex injectable assets expresspharma
August 07, 2020
The two assets, which are in the oncology and anti-infective therapeutic areas, are under development in the US and its territories.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page